Idarubicin 10 mg/10 ml solution for injection
Cytotoxic and antimitotic agent. Adults - For the treatment of acute myeloid leukaemia (AML), for remission induction in untreated patients or for remission induction in relapsed or refractory patients. - For second line treatment of relapsed acute lymphoblastic leukaemia (ALL). Children - For first line treatment of acute myeloid leukaemia (AML), in combination with cytarabine, for remission induction. - For second line treatment of relapsed acute lymphoblastic leukaemia (ALL). Idarubicin Accord may be used in combination chemotherapy regimens involving other cytotoxic agents (see section 4.2).